Video
27 Apr 2021

Early stage considerations for the manufacture and delivery of vaccines webinar

The COVID-19 pandemic has placed a spotlight on the readiness and requirements of pharma packaging companies to support the distribution and delivery of a potential vaccine and selecting the most suitable primary packaging options for drug products is one of the most crucial considerations in the drug development process, according to industry experts speaking in this CPhI China Virtual Expo Connect Webinar, sponsored by Stevanato Group.

Daniel Martinez, Product Manager, Stevanato Group pointed out that speed to market is a primary consideration for vaccine developers, particularly in the current pandemic environment, and keeping the same type of container is essential to reaching this target.

“The advantage of using a vial is that it is a pretty versatile container – it’s good for liquids, it’s good for lyophilized products, powders and cryogenic,” he told the audience, noting that some of the COVID-19 vaccines being developed need to be stored at -70 degrees.

Watch the webinar to hear more from Daniel and experts from NRL Enterprise Solutions & IQVIA.

Content provided by our supplier

Stevanato Group SPA

  • IT
  • 2015
    On CPhI since

Other Content from Stevanato Group SPA